- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01206686
The Effect of Time-Slot Scheduling on Flu Vaccination Rates
August 15, 2016 updated by: University of Pennsylvania
Effect of Time-Slot Scheduling on Flu Vaccination Rates
The goal of this project is to see if encouraging an individual to privately choose in advance a narrow time window in which to obtain a flu vaccination shot affects the likelihood that he or she will become vaccinated.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Influenza causes 36,000 U.S. deaths per year, but influenza immunization rates average just 28%.
Behavioral "nudges" may increase the effectiveness of immunization reminder mailers at little or no added cost.
Past psychology research has demonstrated that prompting people to form an implementation plan of the form, "When situation x arises, I will implement response y," increases attainment of desired goals because the desired behavior is linked to a concrete future moment.
We study whether adding a planning prompt to a vaccination reminder mailer increases immunization rates.
Study Type
Interventional
Enrollment (Anticipated)
50000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- seasonal influenza vaccine indications according to the CDC
- employees of partner corporations executing study
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control
|
Patients were provided with basic information (present in all conditions) about when and where they could receive a flu shot, but they were given no further treatment.
|
|
Experimental: 1 Hour Planning Prompt
|
Patients were prompted to write down a planned date (and in some cases time) for receiving a flu shot.
|
|
Experimental: 2 Hour Planning Prompt
|
Patients were prompted to write down a planned date (and in some cases time) for receiving a flu shot.
|
|
Experimental: 1 Day Planning Prompt
|
Patients were prompted to write down a planned date (and in some cases time) for receiving a flu shot.
|
|
Experimental: Default Planning Prompt
|
Patients were given a suggested date and time for receiving a flu shot.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Receipt of seasonal influenza vaccination
Time Frame: up to 30 weeks
|
up to 30 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Katherine L Milkman, Ph.D., University of Pennsylvania
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2009
Primary Completion (Actual)
July 1, 2012
Study Completion (Actual)
July 1, 2012
Study Registration Dates
First Submitted
September 14, 2010
First Submitted That Met QC Criteria
September 20, 2010
First Posted (Estimate)
September 22, 2010
Study Record Updates
Last Update Posted (Estimate)
August 17, 2016
Last Update Submitted That Met QC Criteria
August 15, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 810589
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Seasonal Influenza
-
National Institute of Allergy and Infectious Diseases...RecruitingSeasonal Influenza | Influenza PreventionUnited States
-
Novartis VaccinesCompletedInfluenza | Seasonal Influenza | Human Influenza | Influenza Due to Unspecified Influenza VirusBelgium
-
Sinovac Biotech Co., LtdCompletedA Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 MonthsSeasonal InfluenzaChina
-
Sinovac Biotech Co., LtdCompletedSeasonal InfluenzaChina
-
ModernaTX, Inc.CompletedSeasonal InfluenzaUnited States
-
ModernaTX, Inc.Completed
-
NovartisNovartis VaccinesCompletedSeasonal InfluenzaGermany
-
Novartis VaccinesCompleted
-
Novartis VaccinesCompleted
-
University of OxfordCompletedSeasonal InfluenzaUnited Kingdom
Clinical Trials on Planning Prompt
-
University of PennsylvaniaCompletedIn Need of a Pap Smear (Cervical Cancer Screening) | In Need of a Blood Pressure Check (Hypertension Screening) | In Need of a Cholesterol Test (Lipid Disorder Screening) | In Need of a Fasting Plasma Glucose Test (Diabetes)United States
-
University of PennsylvaniaYale University; Stanford University; Harvard UniversityCompletedSeasonal InfluenzaUnited States
-
University of California, Los AngelesUCLA Health Department of MedicineCompletedDiabetes | Cancer | Health MaintenanceUnited States
-
Ottawa Heart Institute Research CorporationActive, not recruitingMitral Regurgitation (MR) | Moderate or Severe Aortic Stenosis (AS) (Mean Pressure Gradient ≥ 20 mm Hg or Aortic Valve Area ≤ 1.5 cm2)Canada
-
The Prompt InstituteCompletedRandomized Controlled Trial for Speech Disorders in ChildrenCanada
-
University of CincinnatiRobert Wood Johnson FoundationCompleted
-
Virtua Health, Inc.Rutgers UniversityTerminated
-
Stanford UniversityActive, not recruiting
-
St. Joseph's Healthcare HamiltonCompleted
-
University of PennsylvaniaCompletedBlood Pressure Check (Hypertension Screening) | Cholesterol Test (Lipid Disorder Screening)United States